South Korea vs New Zealand: Average non-HDL cholesterol levels
South Korea
3.4
in 2018
New Zealand
3.4
in 2018
South Korea rank
75th
New Zealand rank
75th
Average non-HDL cholesterol levels over time
- South Korea
- New Zealand
How they compare
South Korea currently reports 3.4 against 3.4 in New Zealand, a difference of 0.
The two have swapped places 2 times across 39 shared years of data; in 1980 it was New Zealand ahead.
South Korea ranks 75th and New Zealand ranks 75th of 191 countries.
New Zealand has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | South Korea | New Zealand | Difference | Ahead |
|---|---|---|---|---|
| 1980s | 3.56 | 4.48 | 0.92 | New Zealand |
| 1990s | 3.6 | 4.31 | 0.71 | New Zealand |
| 2000s | 3.56 | 3.92 | 0.36 | New Zealand |
| 2010s | 3.49 | 3.53 | 0.0444 | New Zealand |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher average non-hdl cholesterol levels, South Korea or New Zealand?
- South Korea, at 3.4 against 3.4 in New Zealand as of 2018.
- What is the difference in average non-hdl cholesterol levels between South Korea and New Zealand?
- 0, with South Korea ahead.
- How many years of comparable data are there for South Korea and New Zealand?
- 39 years are reported by both, from 1980 to 2018.
- How do South Korea and New Zealand rank globally for average non-hdl cholesterol levels?
- South Korea ranks 75th and New Zealand ranks 75th of 191 countries.
- Where does this data come from?
- World Health Organization - Global Health Observatory (2026) – with minor processing by Our World in Data, published as Average non-HDL cholesterol levels. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The estimated average level of non-high-density lipoprotein (non-HDL) cholesterol, commonly known as "bad cholesterol". Healthy levels are considered to be under 4mmol/L. Elevated levels of non-HDL cholesterol are a risk factor for chronic complications, including cardiovascular disease, and premature death.